ELTX- Elicio Therapeutics, Inc.

Name: Elicio Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Elicio Therapeutics, Inc. (ELTX) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. ELTX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Chudnovsky Yekaterina	103.2K	$1.06M	-
Other	Haqq Christopher	57.4K	$591.6K	-
Dir	Venkatesan Jay	7.9K	$81.4K	-
Dir	Nissenson Allen	7.9K	$81.4K	-
Dir	Ruffolo Robert R	7.9K	$81.4K	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 14, 2021	Rhodes Jennifer J95	See Remarks	Sell	451	$2.42	$1,090.11	-1.5%	-26.8%	-65.5%
Dec 6, 2021	Goldberg Itzhak85	See Remarks	Sell	32,118	$3.35	$107,720.56	-1.8%	-45.6%	-75.1%
Dec 3, 2021	Goldberg Itzhak85	See Remarks	Sell	117,882	$3.48	$410,210.84	-2.1%	-41.9%	-72.5%
Nov 18, 2021	Neylan John F.95	See Remarks	Sell	374	$4.13	$1,544.62	-1.0%	-47.8%	-79.2%
Nov 16, 2021	Goldberg Itzhak85	See Remarks	Sell	150,000	$4.19	$629,051.24	-3.8%	-49.4%	-79.4%
Nov 15, 2021	Rhodes Jennifer J95	See Remarks	Sell	433	$4.40	$1,905.20	-1.4%	-49.2%	-79.8%
Oct 18, 2021	Neylan John F.95	See Remarks	Sell	373	$8.62	$3,215.26	-1.0%	-74.0%	-87.4%
Oct 14, 2021	Rhodes Jennifer J95	See Remarks	Sell	430	$8.65	$3,719.50	-1.4%	-68.3%	-88.2%
Sep 20, 2021	Neylan John F.95	See Remarks	Sell	376	$10.07	$3,786.32	-1.0%	-73.5%	-89.7%
Sep 14, 2021	Rhodes Jennifer J95	See Remarks	Sell	430	$10.64	$4,575.20	-1.3%	-76.4%	-88.9%

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC